FDA Approved: DDAVP — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for DDAVP (desmopressin acetate) from Ferring Pharmaceuticals Inc., updating the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Diabetes Insipidus
• Hemophilia
• Nocturnal Enuresis
• Von Willebrand Disease

Drugs mentioned

• DDAVP (desmopressin acetate)

Snippet

SUPPL AP for DDAVP (DESMOPRESSIN ACETATE)